COATS LONNEL

CIK 00016125284 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001612528

Recent Transactions

50 trades

Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2026-06-09+32,947→ 32,947 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2025-11-04+207,931→ 207,931 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−136,139→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−42,200→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−3,188→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−6,144→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,875→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−10,909→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−10,909→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,570→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−11,818→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-06-18$12812.00/sh+3,902→ 6,144 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-06-05+42,200→ 42,200 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-21$94.87/sh−9,824→ 2,242 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-20$94.24/sh−5,287→ 12,279 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-20$93.15/sh−4,500→ 17,566 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-11-20$76.24/sh+1,312→ 22,066 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-11-20$69.79/sh+7,500→ 20,754 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-11-20−7,500→ 0 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-20$94.99/sh−213→ 12,066 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-11-20−1,312→ 3,188 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-06-26+136,139→ 136,139 total
Award
Blueprint Medicines Corp
Common Stock
2024-06-12+2,242→ 13,254 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-06-12+4,570→ 4,570 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+120,383→ 1,159,439 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+91,364→ 1,039,056 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28+33,333→ 947,692 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−120,383→ 240,767 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-02-28$2.62/sh−61,371→ 1,098,068 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−91,364→ 91,363 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-28−33,333→ 0 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2024-02-08+770,420→ 770,420 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2024-02-08+770,420→ 770,420 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-11-16$1.05/sh+90,000→ 914,359 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-11-10$1.01/sh+10,000→ 824,359 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-29$2.16/sh+10,000→ 814,359 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-26$2.18/sh+10,000→ 804,359 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-23$2.50/sh+10,000→ 794,359 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-22$2.31/sh+40,000→ 784,359 total
Award
Blueprint Medicines Corp
Common Stock
2023-06-21+2,600→ 11,012 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-06-21
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-06-15+26,642→ 26,642 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−91,363→ 182,727 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−84,630→ 0 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28$2.17/sh−50,971→ 744,359 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2023-02-28−33,334→ 33,333 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-02-28+91,363→ 795,330 total

Companies

Recent Filings

Address

C/O RELAY THERAPEUTICS, INC. 60 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov